Bioanalytics
Brian Booth, PhD
Director, DCP I
FDA
Silver Spring, Maryland
Brian Booth, Director, Division of Clinical Pharmacology I, FDA will be holding an interactive discussion with the audience on the regulations and issues facing the bioanalytical community. Activities of the FDA that are of interest to bioanalysts will be commented on. Questions are welcome to help resolve current scientific and regulatory uncertainty.